ANVS - Annovis Bio GAAP EPS of -$0.10 beats by $0.53
2024-05-13 07:59:02 ET
More on Annovis Bio
- Annovis Bio: Alzheimer's Disease Topline Data Disappoints The Market
- Impact Of Buntanetap Trial Results On Annovis Bio Stock And Future Prospects
- Annovis Bio: Alzheimer's Phase 2/3 Topline Readout Puts Future For Buntanetap Into Question
- Annovis Bio to post late-stage data for Parkinson's drug in June
- Annovis Bio tumbles 53% on data for Alzheimer's candidate buntanetap